Categories: AppArtificial IntelligenceDataDrugHumanOptimizePlatform
Guided by our powerful AI capabilities, Terray leverages vast high-quality data to optimize the path from discovery to transformative therapeutics.
Investors 4
Mentions in press and media 4
| Date | Title | Description |
| 22.10.2024 | Terray Therapeutics: $120 Million (Series B) Secured To Improve Human Health | Terray Therapeutics, a biotechnology company focused on improving human health by transforming the speed, cost, and success rate of small molecule drug development using computation integrated with novel data at scale, announced Series B fu... |
| 18.10.2024 | The Week’s 10 Biggest Funding Rounds: X-energy And Lightmatter Lead The Way | 3 Shares Email Facebook Twitter LinkedIn
Want to keep track of the largest startup funding deals in 2024 with our curated list of $100 million-plus venture deals to U.S.-based companies? Check out The Crunchbase Megadeals Board.
This is a w... |
| 17.10.2024 | Terray Therapeutics Closes $120M Series B Funding Round | Terray Therapeutics, a Los Angeles, CA-based biotechnology company improving human health by enhancing small molecule drug development, raised $120M in Series B funding.
The round was led by Bedford Ridge Capital and existing investor NVent... |
| - | Terray Therapeutics | “Terray exists to change the way experimentation and computation work together. We believe high-quality data at scale is the key to unlocking generative AI for small molecules. ” |
Reviews 0
